Functions of Nuclear Factor KappaB in Bone

Overview

Journal Ann N Y Acad Sci

Specialty Science

Date 2010 Apr 16

PMID 20392262

Citations 81

Authors

Brendan F Boyce

Zhenqiang Yao

Lianping Xing

Affiliations

Soon will be listed here.

Abstract

Nuclear factor kappaB (NF-kappaB) is a set of multifunctional transcription factors that regulate expression of genes involved in numerous normal cellular activities. They also are activated in many inflammatory and neoplastic conditions in which their expression may be stimulated by proinflammatory cytokines. NF-kappaB, in turn, regulates the expression of cytokines and so can mediate autocrine self-amplifying cycles of cytokine release and NF-kappaB activation, leading to maintenance of inflammatory reactions beyond the initial stimulus, as seen in rheumatoid arthritis and asthma. Since discovery of the requirement of NF-kappaB for basal and cytokine-induced osteoclast formation in the mid-1990s, much has been learned about the role of NF-kappaB in bone. NF-kappaB has roles in skeletal development, endochondral ossification, osteoclast and osteoblast functions, and common bone diseases. NF-kappaB inhibitors have been developed, but none have made it to clinical trials for the treatment of common bone diseases. Here we review the roles for NF-kappaB in bone and in common bone diseases.

Citing Articles

Distribution of Immunomodulation, Protection and Regeneration Factors in Cleft-Affected Bone and Cartilage.

Vaivads M, Pilmane M Diagnostics (Basel). 2024; 14(19).

PMID: 39410621 PMC: 11475217. DOI: 10.3390/diagnostics14192217.

A mechanistic study on the toluidine blue/ photodynamic therapy inhibition of lipopolysaccharide-induced inflammatory response in rat gingival fibroblasts.

Zhao S, Fu Y, Li Y, Lin J, Su X Lasers Med Sci. 2024; 39(1):187.

PMID: 39031220 DOI: 10.1007/s10103-024-04149-1.

Role of O-linked N-acetylglucosamine protein modification in oxidative stress-induced autophagy: a novel target for bone remodeling.

Li S, Ren W, Zheng J, Li S, Zhi K, Gao L Cell Commun Signal. 2024; 22(1):358.

PMID: 38987770 PMC: 11238385. DOI: 10.1186/s12964-024-01734-3.

The influence of uremic toxins on low bone turnover disease in chronic kidney disease.

Yiang G, Su W, Zheng C, Liao M, Cheng T, Lu C Tzu Chi Med J. 2024; 36(1):38-45.

PMID: 38406573 PMC: 10887346. DOI: 10.4103/tcmj.tcmj_212_23.

Garcinone C attenuates RANKL-induced osteoclast differentiation and oxidative stress by activating Nrf2/HO-1 and inhibiting the NF-kB signaling pathway.

Ji H, Pan Q, Cao R, Li Y, Yang Y, Chen S Heliyon. 2024; 10(3):e25601.

PMID: 38333852 PMC: 10850749. DOI: 10.1016/j.heliyon.2024.e25601.

References

Otero J, Dai S, Foglia D, Alhawagri M, Vacher J, Pasparakis M . Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation. J Biol Chem. 2008; 283(36):24546-53. PMC: 2528995. DOI: 10.1074/jbc.M800434200. View

Fusco A, Savinova O, Talwar R, Kearns J, Hoffmann A, Ghosh G . Stabilization of RelB requires multidomain interactions with p100/p52. J Biol Chem. 2008; 283(18):12324-32. PMC: 2431000. DOI: 10.1074/jbc.M707898200. View

Vaira S, Johnson T, Hirbe A, Alhawagri M, Anwisye I, Sammut B . RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proc Natl Acad Sci U S A. 2008; 105(10):3897-902. PMC: 2268780. DOI: 10.1073/pnas.0708576105. View

Kanazawa K, Kudo A . TRAF2 is essential for TNF-alpha-induced osteoclastogenesis. J Bone Miner Res. 2005; 20(5):840-7. DOI: 10.1359/JBMR.041225. View

Vallabhapurapu S, Karin M . Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 2009; 27:693-733. DOI: 10.1146/annurev.immunol.021908.132641. View

Karsenty G, Wagner E . Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002; 2(4):389-406. DOI: 10.1016/s1534-5807(02)00157-0. View

Shibata W, Maeda S, Hikiba Y, Yanai A, Ohmae T, Sakamoto K . Cutting edge: The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis. J Immunol. 2007; 179(5):2681-5. DOI: 10.4049/jimmunol.179.5.2681. View

Xu J, Wu H, Ang E, Yip K, Woloszyn M, Zheng M . NF-kappaB modulators in osteolytic bone diseases. Cytokine Growth Factor Rev. 2008; 20(1):7-17. DOI: 10.1016/j.cytogfr.2008.11.007. View

Darnay B, Besse A, Poblenz A, Lamothe B, Jacoby J . TRAFs in RANK signaling. Adv Exp Med Biol. 2007; 597:152-9. DOI: 10.1007/978-0-387-70630-6_12. View

10.

Yilmaz Z, Weih D, Sivakumar V, Weih F . RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J. 2002; 22(1):121-30. PMC: 140043. DOI: 10.1093/emboj/cdg004. View

11.

Asagiri M, Sato K, Usami T, Ochi S, Nishina H, Yoshida H . Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med. 2005; 202(9):1261-9. PMC: 2213228. DOI: 10.1084/jem.20051150. View

12.

Wehling N, Palmer G, Pilapil C, Liu F, Wells J, Muller P . Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Arthritis Rheum. 2009; 60(3):801-12. PMC: 2688727. DOI: 10.1002/art.24352. View

13.

Burkiewicz J, Scarpace S, Bruce S . Denosumab in osteoporosis and oncology. Ann Pharmacother. 2009; 43(9):1445-55. DOI: 10.1345/aph.1M102. View

14.

Chaisson M, Branstetter D, Derry J, Armstrong A, Tometsko M, Takeda K . Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha. J Biol Chem. 2004; 279(52):54841-8. DOI: 10.1074/jbc.M406392200. View

15.

Xing L, Carlson L, Story B, Tai Z, Keng P, Siebenlist U . Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption. J Bone Miner Res. 2003; 18(2):260-9. DOI: 10.1359/jbmr.2003.18.2.260. View

16.

Ahmed K, Li J . NF-kappa B-mediated adaptive resistance to ionizing radiation. Free Radic Biol Med. 2007; 44(1):1-13. PMC: 2266095. DOI: 10.1016/j.freeradbiomed.2007.09.022. View

17.

Akiyama H . Control of chondrogenesis by the transcription factor Sox9. Mod Rheumatol. 2008; 18(3):213-9. DOI: 10.1007/s10165-008-0048-x. View

18.

Jung Y, Song J, Shiozawa Y, Wang J, Wang Z, Williams B . Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche. Stem Cells. 2008; 26(8):2042-51. PMC: 3513687. DOI: 10.1634/stemcells.2008-0149. View

19.

Li Y, Li A, Strait K, Zhang H, Nanes M, Weitzmann M . Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB. J Bone Miner Res. 2007; 22(5):646-55. DOI: 10.1359/jbmr.070121. View

20.

Pulai J, Chen H, Im H, Kumar S, Hanning C, Hegde P . NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol. 2005; 174(9):5781-8. PMC: 2903737. DOI: 10.4049/jimmunol.174.9.5781. View